You're reading everything related to:

european recreational cannabis

Product testing in Australia reveals inconsistencies over cannabinoid potency

Last Friday, Australian regulator TGA published test results on the most common medical cannabis products sold in Australia. Results, which showed 23% of products had cannabinoid levels which differed from...

Prohibition Partners LIVE returns this November with global cannabis conference

Cannabis market set to offer welcome relief during global recession

European Cannabis: Waking The Sleeping Giant

The consolidation of fully legalised and regulated cannabis industries in North America has powered hope that the same progressive systems might be implemented as quickly and successfully elsewhere. However, the...

Prohibition Partners Interviews Pharmin’s CEO Ana Kobalia

Pharmin is a vertically integrated Uruguayan company, formed in June 2019 as a result of a transnational partnership of experienced and successful entrepreneurs. Today, the company is proud of its...

Germany: Insured medicinal cannabis sales worth €75 million in the first half of 2020

New data just released from the National Association of Statutory Health Insurance Funds (GKV) shows continued year on year growth of the German medicinal cannabis market, despite signs that growth...

Recreational cannabis projects beginning to emerge in Europe

Prohibitionist ideologies embedded in the international narcotic treaties have hampered the development of legal recreational cannabis programmes in Europe. However, we have seen the emergence of cannabis social clubs and...

news

intelligence

insights

on the cannabis market

Our weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry.